TScan Therapeutics Inc. (TCRX)
Market Open
11 Sep, 14:42
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 31
-0.01
-2.0447%
$
21.06M Market Cap
- P/E Ratio
- Div Yield
295,809 Volume
-1.04 Eps
$ 0.32
Previous Close 
Want to track TCRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Lags Revenue Estimates
TScan Therapeutics, Inc. (TCRX) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.30. This compares to loss of $0.51 per share a year ago.
Zacks | 2 years ago
